ANXA5 and acute lymphoblastic leukemia: In primary TTLshort ALL cells, both inhibitors showed no increase in cell death, Annexin-V positivity, caspase 3 cleavage or LC3 conversion at different time points, indicating no induction of overall cell death, apoptosis or autophagy (FIGURE 3E, F, G, H).